Abbott | ABT - Marktkapitalisierung

Aktienkurs
91.90
Täglich Wechseln
0.77 0.84%
Monatlich
-9.80%
Jährlich
-29.05%
Q2 Prognose
89.18




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Agilent USD 37.86B 3.64B 2025-12
AtriCure USD 1.97B 215M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Boston Scientific USD 95.61B 2.35B 2026-04
Cooper Companies USD 15.95B 2.05B 2025-12
Danaher USD 140.45B 11.98B 2026-04
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 47.05B 884M 2026-04
Globus Medical USD 11.69B 3.95B 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
J&J USD 561.65B 17.5B 2026-04
Masimo USD 6.84B 839M 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Smith & Nephew USD 3.77B 9.55B 2026-04
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
WK Kellogg Co USD 13.74B 1.09B 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12